Story perspectives

New AI Tool Predicts Esophageal Cancer Risk with 90% Accuracy

4/7/2026

Summary

Story summary

A new AI tool shows over 90% accuracy in predicting recurrence risk for Barrett's esophagus-related dysplasia and early esophageal adenocarcinoma.
Developed by U.S. researchers, it analyzes data from more than 2,500 patients to tailor follow-up care.
The tool enables closer monitoring for high-risk individuals and reduces unnecessary tests for low-risk patients.
Future validation will involve international datasets from multiple countries to ensure broad applicability in clinical settings.

1 of 1

Story summary

A new AI tool shows over 90% accuracy in predicting recurrence risk for Barrett's esophagus-related dysplasia and early esophageal adenocarcinoma.
Developed by U.S. researchers, it analyzes data from more than 2,500 patients to tailor follow-up care.
The tool enables closer monitoring for high-risk individuals and reduces unnecessary tests for low-risk patients.
Future validation will involve international datasets from multiple countries to ensure broad applicability in clinical settings.